UBS Group
CORZ

UBS Group’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

UBS Group’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-142,661
Closed -$11.4K – 11541
2022
Q4 		$11.4K Buy
142,661
+131,246
+1,150% +$60.2K ﹤0.01% 8402
2022
Q3 		$15K Buy
+11,415
New +$24.3K ﹤0.01% 7878
2022
Q1 		– Sell
-7,397
Closed -$81K – 11353
2021
Q4 		$81K Buy
+7,397
New +$87.2K ﹤0.01% 6498

Other funds holding CORZ

SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CWC
Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return
BWP
BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

UBS Group's CORZ Position: Q1 2023 in Review

UBS Group sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 142,661 shares — an estimated $11.4K sold.

UBS Group first reported a position in CORZ in Q4 2021 and held it in 3 quarters. The position peaked at $81K in Q4 2021. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

  • UBS Group reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 142,661 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $11.4K.
  • UBS Group first reported a position in Core Scientific, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • UBS Group's Core Scientific, Inc. Common Stock position peaked at $81K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.